Clinical Trials Browser

INDUSTRY × Papillomavirus Infections × 1 year × Clear all

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections

NCT05119855 2026-02-05

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Phase 3 Completed

165 enrolled 13 charts

COVID-19, Papillomavirus Infections

NCT07281599 2026-02-02

EQUIP

Phase NA Recruiting

Genital Diseases, Uterine Cervical Neoplasms, Sexually Transmitted Diseases, Sexually Transmitted Diseases, Viral, Papillomavirus Infections

NCT06632912 2026-01-23

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Phase 3 Active not recruiting

Infections, Papillomavirus Infections

NCT05262010 2026-01-16

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

Phase 3 Recruiting

13,500 enrolled

Papillomavirus Infections

NCT04210336 2025-12-18

PAPILOCAN

Phase NA Completed

Papillomavirus Infections

NCT06756269 2025-12-17

To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years

Phase 2 Recruiting

Condylomata Acuminata, Papillomavirus Infections

NCT06538480 2025-12-15

Zopa Retreatment and Vector Shedding in Adults With RRP

Phase 4 Recruiting

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT06285357 2025-11-20

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Phase NA Recruiting

Papillomavirus Infections

NCT04098744 2025-10-02

ART-CIN_IIB

Phase 2 Recruiting

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT04607850 2025-08-28

Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions

Phase 1/2 Completed

Papillomavirus Infections

NCT06075264 2025-08-14

ART-VIN IIB

Phase 2 Recruiting

Vulvar Diseases, Papillomavirus Infections

NCT05592626 2025-07-09

START-001

Phase 1/2 Recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Phase 1/2 Active not recruiting

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT04772534 2025-05-30

V503-066

Phase 3 Completed

314 enrolled 12 charts

Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

Phase 2 Active not recruiting

Papillomavirus Infections

NCT06959563 2025-05-13

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

Papillomavirus Infections

NCT04708041 2025-04-20

V503-069

Phase 3 Active not recruiting

Papillomavirus Infections

NCT04199689 2025-03-25

V503-049

Phase 3 Active not recruiting

Papillomavirus Infections

NCT03903562 2025-03-24

V503-024

Phase 3 Completed

Papillomavirus Infections